These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16300225)

  • 1. Optimal antibacterial treatment of uncomplicated skin and skin structure infections: applying a novel treatment algorithm.
    Elston DM
    J Drugs Dermatol; 2005; 4(6 Suppl):s15-9. PubMed ID: 16300225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Lawrence KR; Golik MV; Davidson L
    Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
    Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
    Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of understanding pharmacokinetic/pharmacodynamic principles in the emergence of resistances, including community-associated Staphylococcus aureus.
    Fritsche TR; Jones RN
    J Drugs Dermatol; 2005; 4(6 Suppl):s4-8. PubMed ID: 16300223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.
    Giordano PA; Elston D; Akinlade BK; Weber K; Notario GF; Busman TA; Cifaldi M; Nilius AM
    Curr Med Res Opin; 2006 Dec; 22(12):2419-28. PubMed ID: 17257456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral beta-lactams applied to uncomplicated infections of skin and skin structures.
    Jacobs MR; Jones RN; Giordano PA
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):55S-65S. PubMed ID: 17292581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute bacterial skin infections in pediatric medicine: current issues in presentation and treatment.
    Hedrick J
    Paediatr Drugs; 2003; 5 Suppl 1():35-46. PubMed ID: 14632104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus.
    Stryjewski ME; Chambers HF
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S368-77. PubMed ID: 18462092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-acquired methicillin-resistant Staphylococcus aureus infections of the hand: prevalence and timeliness of treatment.
    O'Malley M; Fowler J; Ilyas AM
    J Hand Surg Am; 2009 Mar; 34(3):504-8. PubMed ID: 19258149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of community-associated methicillin-resistant Staphylococcus aureus infections in children.
    Le J; Lieberman JM
    Pharmacotherapy; 2006 Dec; 26(12):1758-70. PubMed ID: 17125437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of community-acquired methicillin-resistant Staphylococcus aureus in a private dermatology office.
    Bruce AM; Spencer JM
    J Drugs Dermatol; 2008 Aug; 7(8):751-5. PubMed ID: 18720691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic options for treating community-acquired MRSA.
    Powell JP; Wenzel RP
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):299-307. PubMed ID: 18588495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-acquired MRSA infections in North Carolina children: prevalence, antibiotic sensitivities, and risk factors.
    Shapiro A; Raman S; Johnson M; Piehl M
    N C Med J; 2009; 70(2):102-7. PubMed ID: 19489364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of community-acquired Staphylococcus aureus infections in children.
    Johnson PN; Rapp RP; Nelson CT; Butler JS; Overman S; Kuhn RJ
    Ann Pharmacother; 2007 Sep; 41(9):1361-7. PubMed ID: 17652124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome.
    Ruhe JJ; Smith N; Bradsher RW; Menon A
    Clin Infect Dis; 2007 Mar; 44(6):777-84. PubMed ID: 17304447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and -resistant Staphylococcus aureus: results from the CORE Registry.
    Martone WJ; Lamp KC
    Curr Med Res Opin; 2006 Dec; 22(12):2337-43. PubMed ID: 17257448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tigecycline: the answer to beta-lactam and fluoroquinolone resistance?
    Fraise AP
    J Infect; 2006 Nov; 53(5):293-300. PubMed ID: 16876253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic experience with cefdinir in the treatment of uSSSIs.
    Del Rosso J
    Int J Clin Pract; 2006 Oct; 60(10):1313-6. PubMed ID: 16780571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-acquired methicillin-resistant Staphylococcus aureus skin infections: report of a local outbreak and implications for emergency department care.
    Fleming SW; Brown LH; Tice SE
    J Am Acad Nurse Pract; 2006 Jun; 18(6):297-300. PubMed ID: 16719849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-acquired methicillin resistant Staphylococcus aureus skin infection.
    Halem M; Trent J; Green J; Kerdel F
    Semin Cutan Med Surg; 2006 Jun; 25(2):68-71. PubMed ID: 16908395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.